Loading clinical trials...
Loading clinical trials...
Evaluation of RAD001 as Therapy for Patients With Systemic Mastocytosis
Conditions
Interventions
RAD001 (Everolimus)
Locations
1
United States
The University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
Start Date
April 1, 2007
Primary Completion Date
October 1, 2009
Completion Date
October 1, 2009
Last Updated
May 1, 2025
NCT07142473
NCT05186753
NCT03770273
NCT05504408
NCT02561988
NCT03214666
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions